Business Description
Mereo BioPharma Group PLC
Share Class Description:
HAM:MAH0: ADRDescription
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.65 | |||||
Equity-to-Asset | 0.76 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | -0.23 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 13.81 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 60.4 | |||||
3-Year EPS without NRI Growth Rate | 39.9 | |||||
3-Year FCF Growth Rate | 34.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.8 | |||||
9-Day RSI | 57.44 | |||||
14-Day RSI | 59.08 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 6.72 | |||||
Quick Ratio | 6.72 | |||||
Cash Ratio | 6.05 | |||||
Days Sales Outstanding | 363.36 | |||||
Days Payable | 389.86 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -27.5 | |||||
Shareholder Yield % | -0.31 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 74.26 | |||||
Operating Margin % | -271.36 | |||||
Net Margin % | -294.66 | |||||
FCF Margin % | -215.35 | |||||
ROE % | -50.58 | |||||
ROA % | -35.99 | |||||
ROIC % | -111.12 | |||||
ROC (Joel Greenblatt) % | -1393.24 | |||||
ROCE % | -42.87 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 47.25 | |||||
PB Ratio | 10.47 | |||||
Price-to-Tangible-Book | 10.76 | |||||
EV-to-EBIT | -20.85 | |||||
EV-to-EBITDA | -21.7 | |||||
EV-to-Revenue | 56.55 | |||||
EV-to-FCF | -26.24 | |||||
Price-to-Net-Current-Asset-Value | 11.09 | |||||
Price-to-Net-Cash | 12.68 | |||||
Earnings Yield (Greenblatt) % | -4.8 | |||||
FCF Yield % | -3.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mereo BioPharma Group PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 9.224 | ||
EPS (TTM) (€) | -0.024 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 59.08 | ||
14-Day ATR (€) | 0.125954 | ||
20-Day SMA (€) | 3.2705 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (€) | 2.36 - 3.91 | ||
Shares Outstanding (Mil) | 152.8 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Mereo BioPharma Group PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Mereo BioPharma Group PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Mereo BioPharma Group PLC Frequently Asked Questions
What is Mereo BioPharma Group PLC(HAM:MAH0)'s stock price today?
The current price of HAM:MAH0 is €3.55. The 52 week high of HAM:MAH0 is €3.91 and 52 week low is €2.36.
When is next earnings date of Mereo BioPharma Group PLC(HAM:MAH0)?
The next earnings date of Mereo BioPharma Group PLC(HAM:MAH0) is .
Does Mereo BioPharma Group PLC(HAM:MAH0) pay dividends? If so, how much?
Mereo BioPharma Group PLC(HAM:MAH0) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |